Regulatory
IMGB
Jun 17
▲ +0.50
ImageneBio's Board amended and restated its 2025 Equity Incentive Plan, increasing the share reserve to approximately 2.53 million shares with annual 5% increases through 2036. The…
Regulatory
GRPN
Jun 17
— 0.00
Groupon filed a certificate of amendment to its restated certificate of incorporation to expand protections for directors and officers under Delaware law. The amendment broadens in…
Regulatory
OSR
Jun 17
▼ -0.20
OSR Health, Inc. (formerly OSR Holdings, Inc. and originally Bellevue Life Sciences Acquisition Corp.) filed a Certificate of Revival with Delaware on June 11, 2026 to restore its …
Regulatory
LKWD
Jun 17
— 0.00
The company filed a Certificate of Change with Nevada authorities on June 15, 2026. The filing represents a corporate administrative update but lacks substantive business impact de…
Regulatory
VSTM
Jun 17
▲ +0.75
Verastem Oncology announced positive updated results from RAMP 205 evaluating avutometinib plus defactinib combined with standard chemotherapy in first-line metastatic pancreatic c…
Regulatory
PLBY
Jun 17
— +0.10
Playboy amended its 2021 Equity and Incentive Compensation Plan, raising the overall share limit to 14,262,364 shares with automatic annual increases of up to 4% through 2031. The …
Regulatory
SHF4
Jun 17
— 0.00
Shift4 Payments adopted an updated certificate of incorporation authorized to issue 320 million shares including 300 million Class A common shares and 20 million preferred shares. …
Regulatory
AVLN
Jun 17
▲ +0.75
Avalyn Pharma announced completion of target enrollment in its Phase 2b MIST clinical trial evaluating AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis, with topline r…
Regulatory
ELTX
Jun 17
▲ +0.75
Elicio Therapeutics reported that three metastatic pancreatic cancer patients achieved confirmed complete responses after receiving ELI-002 7P followed by nivolumab-based therapy, …
Regulatory
MIRA
Jun 17
▲ +0.75
Mira Pharmaceuticals announced submission of a Phase 2a clinical trial protocol for Ketamir-2, an oral NMDA receptor modulator, to treat chemotherapy-induced peripheral neuropathy …
Regulatory
QURE
Jun 17
▲ +0.85
The FDA agreed that uniQure's 3-year Phase I/II data for AMT-130 can serve as the primary basis for accelerated approval of the gene therapy for Huntington's disease, with BLA subm…
Regulatory
BGDE
Jun 17
▲ +0.75
Big Digital Energy received formal notification from Nasdaq confirming it regained compliance with Listing Rule 5550(b)(1) by maintaining stockholders' equity above the $2.5 millio…
Regulatory
OCAC
Jun 17
▼ -0.30
Ocean Capital Acquisition Corp filed audited balance sheet as of June 10, 2026 with PCAOB-registered firm. Auditors raised substantial doubt about going concern status given 12-mon…
Regulatory
CENTA
Jun 16
— 0.00
Shareholders approved a special resolution extending the deadline for completing a business combination from the original date to June 12, 2027, with automatic redemption of public…
Regulatory
EFX
Jun 16
— 0.00
Equifax Inc. filed amended and restated bylaws covering shareholder meetings, board governance, committees, and officer roles. The update reflects standard corporate governance pra…
Regulatory
GLBT
Jun 16
— 0.00
QI CPA LLC confirmed agreement with Global Technologies LTD's Item 4.01 disclosures in an 8-K filed June 16, 2026. The letter indicates a change in auditor or audit-related matter …
Regulatory
KEEL
Jun 16
— 0.00
PricewaterhouseCoopers LLP confirmed agreement with statements made by Keel Infrastructure Corp in an 8-K filing dated June 16, 2026. The letter indicates an auditor change or simi…
Regulatory
NCLH
Jun 16
— +0.10
Norwegian Cruise Line Holdings Ltd. filed an amended and restated 2013 Performance Incentive Plan to enhance equity compensation for employees, officers, directors and consultants.…
Regulatory
MDXG
Jun 16
— 0.00
MiMedx Group updated its amended and restated bylaws to permit shareholders meetings via remote communication and modified special meeting procedures requiring 50% shareholder thre…
Regulatory
NXST
Jun 16
▲ +0.80
Nexstar Media Group shareholders approved all four proposals at the 2026 annual meeting, including board elections, executive compensation, PwC as auditor, and the Long-Term Omnibu…